Global Bronchitis Treatment Market by Indication (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Class of Drugs, End User - Forecast 2024-2030- Product Image

Sale

Global Bronchitis Treatment Market by Indication (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Class of Drugs, End User - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 5337332

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Bronchitis Treatment Market size was estimated at USD 6.72 billion in 2023, USD 7.16 billion in 2024, and is expected to grow at a CAGR of 6.75% to reach USD 10.62 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bronchitis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bronchitis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bronchitis Treatment Market, highlighting leading vendors and their innovative profiles. These include American Well Corporation, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Cigna Corporation, Cipla Limited, Dr. Reddy’s Laboratories Ltd, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Services, Inc, Lupin Limited, Melinta Therapeutics, Inc., Merck and Co. Inc., Novartis International AG, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi S.A, Sun Pharmaceutical Industries Ltd., TelaCare Health Solutions, LLC, Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Bronchitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
- Acute Bronchitis
- Chronic Bronchitis
Treatment
- Drugs
- Oxygen Therapy
Class of Drugs
- Anti-inflammatory Drugs
- Antibiotics
- Bronchodilator
End User
- Clinics
- Hospital Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Bronchitis Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bronchitis Treatment Market?
What are the technology trends and regulatory frameworks in the Bronchitis Treatment Market?
What is the market share of the leading vendors in the Bronchitis Treatment Market?
Which modes and strategic moves are suitable for entering the Bronchitis Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Bronchitis Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic obstructive pulmonary disease (COPD) patients
5.1.1.2. Growing healthcare expenditure by governments and private organizations
5.1.1.3. Increasing initiatives by government and healthcare organizations to create awareness about bronchitis
5.1.2. Restraints
5.1.2.1. Availability of alternatives and high cost of products
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for improving respiratory therapies for bronchitis treatment
5.1.3.2. Increasing preference for personalized medicines for bronchitis treatment
5.1.4. Challenges
5.1.4.1. Time consuming and stringent regulatory environment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Bronchitis Treatment Market, by Indication

6.1. Introduction
6.2. Acute Bronchitis
6.3. Chronic Bronchitis

7. Bronchitis Treatment Market, by Treatment

7.1. Introduction
7.2. Drugs
7.3. Oxygen Therapy

8. Bronchitis Treatment Market, by Class of Drugs

8.1. Introduction
8.2. Anti-inflammatory Drugs
8.3. Antibiotics
8.4. Bronchodilator

9. Bronchitis Treatment Market, by End User

9.1. Introduction
9.2. Clinics
9.3. Hospital Pharmacies
9.4. Retail Pharmacies

10. Americas Bronchitis Treatment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Bronchitis Treatment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Bronchitis Treatment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. American Well Corporation
14.1.2. AstraZeneca PLC
14.1.3. Boehringer Ingelheim International GmbH
14.1.4. Cadila Pharmaceuticals Limited
14.1.5. Cigna Corporation
14.1.6. Cipla Limited
14.1.7. Dr. Reddy’s Laboratories Ltd
14.1.8. F. Hoffmann-La Roche Ltd.
14.1.9. GlaxoSmithKline Pharmaceuticals Limited
14.1.10. Johnson & Johnson Services, Inc
14.1.11. Lupin Limited
14.1.12. Melinta Therapeutics, Inc.
14.1.13. Merck and Co. Inc.
14.1.14. Novartis International AG
14.1.15. Pfizer Inc.
14.1.16. Reckitt Benckiser Group PLC
14.1.17. Sanofi S.A
14.1.18. Sun Pharmaceutical Industries Ltd.
14.1.19. TelaCare Health Solutions, LLC
14.1.20. Teva Pharmaceutical Industries Ltd.
14.1.21. Viatris Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. BRONCHITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. BRONCHITIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. BRONCHITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BRONCHITIS TREATMENT MARKET DYNAMICS
FIGURE 7. BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2030 (%)
FIGURE 12. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BRONCHITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. BRONCHITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BRONCHITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BRONCHITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. BRONCHITIS TREATMENT MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BRONCHITIS TREATMENT MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 9. BRONCHITIS TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BRONCHITIS TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 12. BRONCHITIS TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 35. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 39. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 57. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 61. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 69. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 93. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 106. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 110. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 114. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 130. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 141. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 142. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 146. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 149. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 150. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 165. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. BRONCHITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 188. BRONCHITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 189. BRONCHITIS TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

American Well Corporation
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Cadila Pharmaceuticals Limited
Cigna Corporation
Cipla Limited
Dr. Reddy’s Laboratories Ltd
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Pharmaceuticals Limited
Johnson & Johnson Services, Inc
Lupin Limited
Melinta Therapeutics, Inc.
Merck and Co. Inc.
Novartis International AG
Pfizer Inc.
Reckitt Benckiser Group PLC
Sanofi S.A
Sun Pharmaceutical Industries Ltd.
TelaCare Health Solutions, LLC
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.16 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.62 Billion
Compound Annual Growth Rate	6.7%
Regions Covered	Global
No. of Companies Mentioned	21

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Bronchitis Treatment Global Market Report 2024

Bronchitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Global Bronchitis Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Bronchitis Drugs Market by Drug Type (Anti-inflammatory Drugs, Antibiotics, Bronchodilators), Application (Acute Bronchitis, Chronic Bronchitis) - Forecast 2024-2030

Chronic Bronchitis - Pipeline Insight, 2024